ENTITY
Mezzion Pharma

Mezzion Pharma (140410 KS)

21
Analysis
Health Care • South Korea
Mezzion Pharma Co Ltd develops pharmaceutical products and out-licenses them to foreign countries including Canada, Mexico, Russia, and the United States. The Company's main products are for benign prostatic hyperplasia and erectile dysfunction.
more
bearish•Mezzion Pharma
•17 Mar 2026 15:52

KOSDAQ150 Index Adhoc Rebalance: Curiox Bio (445680 KQ) To Replace Mezzion Pharma (140410 KQ)

Mezzion Pharma has been added to the Investment Attention list and will be deleted from the KOSDAQ150 Index. Curiox Biosystems will be added to the...

Logo
552 Views
Share
bullish•Mezzion Pharma
•17 Mar 2026 10:54

Primer: Mezzion Pharma (140410 KS) - Mar 2026

Mezzion Pharma is a late-stage, single-asset biopharmaceutical company whose value is almost entirely dependent on the clinical and regulatory...

Share
bullish•Seers
•11 Sep 2026 20:34

An Early Look at the Potential KOSDAQ150 Rebalance Candidates in December 2026

In this insight, I provide an early look at the potential additions and deletions to KOSDAQ150 rebalance in December 2026.

Logo
115 Views
Share
•04 Nov 2019 08:45

Stock Short Ideas Within an Index Long Environment

Positioning is quickly shifting to more index net longs and we are on the hunt for stock shorts in Asia given the more bullish Q4 seasonality and...

Share
•26 Aug 2018 23:31

EM Strategy: Remain Overweight India

In this report we provide a synopsis of EM markets. We also scour the EM universe for attractive and actionable opportunities, highlighting...

Logo
613 Views
Share
x